{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:03:24Z","timestamp":1788822204758,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This study was supported by Fraunhofer USA Center for Molecular Biotechnology","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0153956","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T17:42:13Z","timestamp":1461260533000},"page":"e0153956","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum"],"prefix":"10.1371","volume":"11","author":[{"given":"Tarlan","family":"Mamedov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan V.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Herschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey I.","family":"Prokhnevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Streatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidadi","family":"Yusibov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"ref1","first-page":"6","article-title":"An epidemic of inhalation anthrax: the first in the twentieth century. II. Epidemiology","volume":"72","author":"PS Brachman","year":"1960","journal-title":"Am J Hyg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen","volume":"267","author":"SS Molloy","year":"1992","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"AM Friedlander","year":"1999","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/17460913.4.1.35","article-title":"Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax","volume":"4","author":"A Schneemann","year":"2009","journal-title":"Future Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/IAI.73.9.5978-5987.2005","article-title":"Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax","volume":"73","author":"ED Williamson","year":"2005","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.5.4.417","article-title":"Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine","volume":"5","author":"WA Keitel","year":"2006","journal-title":"Exp Rev Vaccin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.3.5.4459","article-title":"Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults","volume":"3","author":"JD Campbell","year":"2007","journal-title":"Hum Vaccin"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.vaccine.2005.10.018","article-title":"A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection","volume":"24","author":"RW Hepler","year":"2006","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pep.2004.08.007","article-title":"Production and purification of <italic>Bacillus anthracis<\/italic> protective antigen from <italic>Escherichia coli<\/italic>","volume":"38","author":"MW Laird","year":"2004","journal-title":"Protein Expr Purif"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.00530-08","article-title":"Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax","volume":"77","author":"J Skoble","year":"2009","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9433-4-4","article-title":"Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin","volume":"4","author":"JY Wang","year":"2005","journal-title":"Med Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"BE Ivins","year":"1998","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2005.12.028","article-title":"Duration of protection of rabbits after vaccination with <italic>Bacillus anthracis<\/italic> recombinant protective antigen vaccine","volume":"24","author":"SF Little","year":"2006","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pbi.2004.01.015","article-title":"Posttranslational modification of therapeutic proteins in plants","volume":"7","author":"V Gomord","year":"2004","journal-title":"Curr Opin Plant Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4161\/hv.23233","article-title":"A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores","volume":"9","author":"JA Chichester","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1467-7652.2012.00694.x","article-title":"Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F","volume":"10","author":"T Mamedov","year":"2012","journal-title":"Plant Biotechnol J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1750-2659.2006.00005.x","article-title":"A launch vector for the production of vaccine antigens in plants","volume":"1","author":"K Musiychuk","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2008.11.108","article-title":"Plant-derived hemagglutinin protects ferrets against challenge infection with the A\/Indonesia\/05\/05 strain of avian influenza","volume":"27","author":"Y Shoji","year":"2009","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12033-014-9806-5","article-title":"Development of a single-replicon miniBYV vector for co-expression of heterologous proteins","volume":"57","author":"A Prokhnevsky","year":"2015","journal-title":"Mol Biotechnol"},{"key":"ref20","article-title":"Optimization and utilization of Agrobacterium-mediated transient protein production in Nicotiana","volume":"86","author":"M Shamloul","year":"2014","journal-title":"J Vis Exp"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0955-0674(92)90134-X","article-title":"Glycosylation","volume":"4","author":"GW Hart","year":"1992","journal-title":"Curr Opin Cell Biol"},{"issue":"Suppl","key":"ref22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4161\/hv.7.0.14586","article-title":"A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge","volume":"7","author":"V Mett","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","article-title":"Immunogenicity of a subunit vaccine against Bacillus anthracis","volume":"25","author":"JA Chichester","year":"2007","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.vaccine.2005.01.013","article-title":"Human-derived, plant-produced monoclonal antibody for the treatment of anthrax","volume":"23","author":"AK Hull","year":"2005","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"SF Little","year":"2004","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"ML Pitt","year":"2001","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2672.1999.00898.x","article-title":"Immune correlates of protection against anthrax","volume":"87","author":"K Fowler","year":"1999","journal-title":"J Appl Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"PF Fellows","year":"2001","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"GJ Gorse","year":"2006","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1128\/IAI.73.12.8266-8274.2005","article-title":"Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge","volume":"73","author":"V Koya","year":"2005","journal-title":"Infect Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-291X(02)02625-6","article-title":"Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax","volume":"299","author":"MA Aziz","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1016\/j.vaccine.2011.03.082","article-title":"A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax","volume":"29","author":"J Gorantala","year":"2011","journal-title":"Vaccine"},{"key":"ref33","first-page":"127","article-title":"Production of recombinant antigens and antibodies in Nicotiana benthamiana using &apos;magnifection&apos; technology: GMP-compliant facilities for small- and large-scale manufacturing","volume":"375","author":"V Klimyuk","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6 Pt 2","key":"ref34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.biotechadv.2015.03.012","article-title":"Transient plant transformation mediated by Agrobacterium tumefaciens: Principles, methods and applications","volume":"33","author":"P K\u0159enek","year":"2015","journal-title":"Biotechnol Adv"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1467-7652.2010.00507.x","article-title":"Plant-made vaccines for humans and animals","volume":"8","author":"EP Rybicki","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.2174\/1381612811319310011","article-title":"The use of transient expression systems for the rapid production of virus-like particles in plants","volume":"19","author":"EC Thuenemann","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.2174\/13816128113199990335","article-title":"Hybrid viral vectors for vaccine and antibody production in plants","volume":"19","author":"V Yusibov","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4161\/hv.7.3.14207","article-title":"Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond","volume":"7","author":"V Yusibov","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/14760584.2015.989988","article-title":"Advances and challenges in the development and production of effective plant-based influenza vaccines","volume":"4","author":"V Yusibov","year":"2015","journal-title":"Expert Rev Vaccines"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0153956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T09:37:57Z","timestamp":1655545077000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0153956"}},"subtitle":[],"editor":[{"given":"N.S.","family":"Duesbery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0153956","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}